US20140236119A1 - Method for Processing Infusion Data and an Infusion Pump System - Google Patents

Method for Processing Infusion Data and an Infusion Pump System Download PDF

Info

Publication number
US20140236119A1
US20140236119A1 US14/182,111 US201414182111A US2014236119A1 US 20140236119 A1 US20140236119 A1 US 20140236119A1 US 201414182111 A US201414182111 A US 201414182111A US 2014236119 A1 US2014236119 A1 US 2014236119A1
Authority
US
United States
Prior art keywords
infusion
pump system
pressure
infusion pump
downstream pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/182,111
Inventor
Achilleas Tsoukalis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Micrel Medical Devices SA
Original Assignee
Micrel Medical Devices SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50151124&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20140236119(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Micrel Medical Devices SA filed Critical Micrel Medical Devices SA
Assigned to MICREL MEDICAL DEVICES S.A. reassignment MICREL MEDICAL DEVICES S.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TSOUKALIS, ACHILLEAS
Publication of US20140236119A1 publication Critical patent/US20140236119A1/en
Priority to US14/791,989 priority Critical patent/US11164667B2/en
Priority to US17/487,135 priority patent/US20220008654A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A61M5/16854Monitoring, detecting, signalling or eliminating infusion flow anomalies by monitoring line pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01LMEASURING FORCE, STRESS, TORQUE, WORK, MECHANICAL POWER, MECHANICAL EFFICIENCY, OR FLUID PRESSURE
    • G01L19/00Details of, or accessories for, apparatus for measuring steady or quasi-steady pressure of a fluent medium insofar as such details or accessories are not special to particular types of pressure gauges
    • G01L19/08Means for indicating or recording, e.g. for remote indication
    • G01L19/12Alarms or signals
    • GPHYSICS
    • G08SIGNALLING
    • G08BSIGNALLING OR CALLING SYSTEMS; ORDER TELEGRAPHS; ALARM SYSTEMS
    • G08B21/00Alarms responsive to a single specified undesired or abnormal condition and not otherwise provided for
    • G08B21/18Status alarms
    • G08B21/182Level alarms, e.g. alarms responsive to variables exceeding a threshold
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M2005/14208Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A61M2005/16863Occlusion detection
    • A61M2005/16868Downstream occlusion sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Definitions

  • the present invention relates to a distributed infusion pump system.
  • downstream pressure is monitored to reveal downstream occlusion.
  • it is known to detect pressure levels of tissue type in subcutaneous infusions or leaks in the line or intravenous needle infiltration.
  • infusion pressure statistics both steady state and transient, below occlusion level, for new medical practice and decisions per therapy.
  • U.S. Pat. No. 8,551,038 discloses an infusion system in which the treatment results and side-effects of infusion are monitored remotely through a server as pumps are online exchanging data through or after therapy.
  • infusion pressure statistics considering both a steady state and a transient state, below occlusion level, for new medical practice and decisions per therapy.
  • Pressure measurements in clinical trials on several infusion sites show that pressure/time graphs define an exponential type like a built-up infusion set occlusion pressure. So, according to the present invention, the pressure is monitored only at steady state and the decay from a given pressure with the pump stopped. This gives another great advantage that an infusion pump is not an ideal current source, as assumed in prior art models, so that the transient measuring when the pump is stopped for few seconds, gives accurate results.
  • the present invention makes use of downstream pressure monitoring not only for short-term deductions concerning leaks but recording an event/pressure profile useful for extraction of useful medical decisions, like ones needed for regional analgesia nerve blocks, but also for long-term conclusions like obstruction of the central venous catheter, venous-SVC stenosis, and catheter blockage in the Parkinson's disease intestinal catheter.
  • the intention of the present invention is to provide an infusion pump system with downstream pressure recording means, to be used within both a short term (one infusion) and a long term over several infusions, for detection of defined problems, as for example infusion catheter blockage, SVC stenosis in chronic patients and regional analgesia nerve blockage complications, and for short term detection of medically useful information, like perineural infusion or generally pain treatment, over one single infusion lasting a few days.
  • Prediction of blockage before the venous catheter actually blocks has significant advantages for the patient, since even at an advanced stage of blockage, if even a small quantity of liquid is able to pass through the catheter, it can be cleaned, thus preventing a surgical intervention for replacement.
  • the type of fluid used in each infusion is recorded, a sampling time interval per therapy having single or multiple infusions duration is defined, and then an average downstream pressure during this interval including maximum pressure and maximum pressure difference is obtained.
  • a pressure reading is always recorded at infusion rate transients even within an interval. Then, both rate and interval pressure statistics are recorded. Further, provided are means to display statistics graphs for one or more infusions, maybe over a day or many months, and for an algorithmic processing of said pressure/rate profiles for extracting medically useful information.
  • Said time interval is limited by data recording capacity of the system, it can be 10 seconds to one hour.
  • a knowledge data base is maintained for each therapy, with fluid/rate/pressure/transient pressure normal data being stored and processed wherein abnormal data can issue a warning.
  • a pressure threshold below occlusion defined per therapy and per site type (subcutaneous, intravenous etc.) and possibly user.
  • occlusion defined per therapy and per site type (subcutaneous, intravenous etc.) and possibly user.
  • special resistance of flow and time constants are measured and added to pressure statistics stored in the data base of the pump or the server (distributed pump system).
  • pressure statistic limits as defined by user are exceeded, an alarm or warning according to the therapy and risks identified is issued.
  • the knowledge is built over a long term, through experience by considering false alarms vs. correct alarms. The risk of percentage of false alarms is taken by user, who defines the amount of false alarms he can accept, just to prevent a higher risk of real alarms that need possibly surgical intervention.
  • warning and/or alarm limits or warning communication are also defined by a user group or the user and the therapy.
  • a user group or the user and the therapy For example, in a clinical study on parenteral nutrition pressure monitoring over hundreds of patients and almost a year of monitoring, only 2 patients showed pressure peaks being higher than 0.5 bar wherein one of them needed a medical intervention (venoplasty) and in the other case there was a false alarm.
  • the risk of false alarms defining 0.5 bar as pressure limit for a catheter vein problem warning is definitively small (1 false over hundreds no-alarm).
  • doctors report false and real alarms to the system stored in the data base per therapy and also user group. So, when a user or doctor selects some alarm and/or warning parameters for a therapy and patient type (fat/slim, race etc.), the system will warn him about the percentage of error these parameters can expect.
  • an aspect of the present invention is the recording of pressure data below occlusion level and creating a graph of said data for deduction of medically useful information.
  • a further aspect of the present invention is the definition of a time interval per therapy for pressure data recording which time interval reduces the data to be sent.
  • a further aspect of the present invention is the measurement of the pressure data not only from one pump as in the prior art, but for many pumps and in many times so as to build up a group knowledge like an ongoing clinical trial.
  • downstream pressure statistics data are grouped in accordance with a) therapy, b) drug, c) way of introduction (intravenous, epidural, perineural, subcutaneous etc.), d) type of delivery (needle, central venous catheter, small perineural catheter, angled needle etc.), e) reported problem type, f) alarm and/or warning level, and g) user type so as to show results according to choices from some or all the aforementioned groups a to g. So, it can be asked e.g. for all reported catheter “type z”, “obstructions” and “statistics” during the “last month of use for each catheter”, so that a query is transferred to the database.
  • Problems are preferably reported to the system by caregivers with reference to category (obstruction of catheter, obstruction of a vein, semi-obstruction etc) and part used (e.g. catheter brand or a model) so as to build up a knowledge on which group of data a problem arises.
  • a risk factor of statistical data and/or reported problems is evaluated by the user or by an automatic computerized process (e.g. comprising neural networks or other artificial intelligence or data filtering and/or algorithmic processing).
  • alarm and warning limits are chosen per user after his risk analysis or acceptance, and then applied to the system, i.e.
  • a distributed infusion pump system comprising
  • FIG. 1 is a graph showing a typical long term pressure recording in parenteral nutrition for various fluids
  • FIG. 2 is a graph showing a transition from a first flow and pressure to a second flow and pressure
  • FIG. 3 shows a typical infusion drug delivery chain
  • FIG. 4 is a graph showing a loading dose and intraneural pressure long drop
  • FIG. 5 is a graph showing a standard subcutaneous loading dose pressure transient.
  • FIG. 3 schematically shows a typical drug delivery chain comprising an infusion set 1 , a connector 2 , a catheter 3 and a tissue or vein 4 wherein the connector 2 couples the infusion set 1 with the catheter 3 which is introduced into the tissue or vein 4 .
  • parenteral nutrition there are different types of infusion, i.e. for main nutrition and for hydration or combination of both (dilutions).
  • the average flow speed for adults is 120 ml/hr, and for hydration it is the maximum pump flow, e.g. 400 ml/hr.
  • Typical parenteral nutrition pressure graphs are shown in FIG. 1 .
  • the pump initially records statistical information about downstream pressure of the infusion such as average pressure, maximum pressure and maximum pressure difference, together with how many peaks happened, and duration per peak, for the entire infusion.
  • Pressure interval one hour
  • Pressure statistics include a calculated flow resistance A and a transient time constant ⁇ .
  • Average can be a real average or the result of digital filtering on the pressure data.
  • Pump system (pump screen or web server) can display graphs of statistical curves, or warn the user if abnormal peaks or trends are found.
  • the system makes time-stamped recordings of the pressure statistics and/or rates, so that a physician or an automated decision-making system evaluates the increase of pressure below occlusion and consequently informs the patient, who can also monitor the pressure statistic curves on the pump. Thanks to local and remote long term recording and the display of pressure statistics, surgical intervention can be avoided.
  • a clinical trial in a hospital has shown that the recording of the statistics on output pressure for each infusion rate in each patient demonstrates the catheter's tendency to block (several months recording).
  • pressure is usually between 0.1 and 0.5 bar. Pressure difference peaks of more than 0.5 bar and, hence, below occlusion level have showed Superior Vena Cava stenosis needing venoplasty.
  • said pressure statistics comprise such resistance of flow.
  • resistance of flow at steady state of intravenous infusions is calculated by the formula
  • A P ⁇ ⁇ 2 - P ⁇ ⁇ 1 F ⁇ ⁇ 2 - F ⁇ ⁇ 1 .
  • FIG. 2 shows a transition from flow F1 and pressure P1 to flow F2 and pressure P2.
  • pressures and corresponding flows recorded in nutrition and hydration are used to calculate the resistance of flow giving indications on the catheter condition.
  • the resistance of flow A is calculated from different pressure and flow which occur with the different infusions and/or even on different days, and this is new in the art.
  • FIG. 1 which as an example shows graphs representing three different flows F1, F2 and F3 under different pressure P1, P2 and P3, respectively. Due to the differing viscosity of different fluids, the flow resistance calculated is not the real figure, but its trend over time reveals whether or not there is a verge of blockage and the catheter needs cleaning. To compensate this, normalized formula for resistance of flow is calculated as
  • the pump can run a slow flow plus a fast flow and calculate the flow resistance, at the beginning or the end of the infusion wherein the end seems best because sugar intake has been completed and the adult patient is not at risk, i.e. flow resistance calculated within one single infusion.
  • the local display at the pump or the remote, mobile or internet application displays the pressure statistics and corresponding flow and also potentially the flow resistance in a diagram chronologically where the trend appears.
  • the derivative of the pressure curve over time i.e. the pressure's tendency to increase over time (days, weeks, months or years) is also displayed, for easy computation by an automated system, the patient or the physician, so as to create a figure or drawing of conclusions regarding the potential blockage of the catheter in the near future.
  • the derivative during and after a bolus gives useful information especially at subcutaneous infusions, where cavities (very slow change) or dead space and/or high change (inside a nerve) can be detected.
  • the system according to the present invention can also be used in cases other than central venous catheters, e.g. for Duodopa infusions in patients with Parkinson's disease, to prevent the blockage of duodenal stomach or peritoneal catheters, in infusions for peripheral analgesia where the involuntary relocation of the catheter near the nerve shows a sudden change in the output pressure, translated into alterations in the analgesia, so that changes to the anaesthetic dosage are required.
  • the resistance of flow is independent of flow.
  • Bolus time may not be generally enough to reach a pressure steady state for the flow rate, so that a measurement of transient fall times is taken for calculating a time constant ⁇ .
  • the flow resistance is not only measured in subcutaneous, epidural and intrathecal infusions, as pressure is built up relatively fast after a flow step, whereas a decay is relatively slow. So, according to the present invention, a transient response to flow and/or pressure only in the pressure decay after a high rate down to zero rate is measured.
  • This measurement is also used in intravenous infusions, stopping for some seconds a relatively high rate (above 100 ml/hr) usual as in intravenous infusions.
  • the recording time interval can be 30 seconds, and the transient pressure after a maximum rate bolus is recorded followed by recording the decay of pressure at a generally low following basal rate, to show if the catheter is placed into a nerve which is potentially harmful to the patient.
  • the pressure rise and fall times are different depending on the placement of a peripheral nerve blocking catheter in surgery. This can give information regarding a reposition of the catheter and the avoidance of complications or a prediction for a based infusion and bolus needed, when the patient goes home.
  • FIG. 5 shows a normal transient response during and after a loading dose and bolus
  • FIG. 4 shows an intraneural transient response i.e. with limited space and elasticity so that the pressure rises abruptly and decays slowly.

Abstract

A distributed infusion pump system is provided with long-term recording of the type of medication, nutrition or hydration, pump output pressure, corresponding infusion flow, infusion flow resistance, and an automatic or manual alarm in the event that thresholds applied to these parameters or their derivatives are exceeded.

Description

  • The present invention relates to a distributed infusion pump system.
  • Usually in infusion pumps, downstream pressure is monitored to reveal downstream occlusion. In the prior art, it is known to detect pressure levels of tissue type in subcutaneous infusions or leaks in the line or intravenous needle infiltration. In the present invention, we use infusion pressure statistics both steady state and transient, below occlusion level, for new medical practice and decisions per therapy.
  • In the case of long-term infusions into a central venous catheter, it is possible that the catheter will become blocked, requiring replacement, which would involve a new surgical intervention and additional discomfort for the patient. This occurs particularly in the case of parenteral nutrition, where the infusion lipids become gradually stratified and eventually block the catheter. A cleaning process is followed after each infusion, but the problem remains and is unpredictable at the current state of the art. Also vein obstructions have not been able to be predicted so far. In case of subcutaneous infusions such wherein the catheter is introduced erroneously into a nerve, which in most of such cases is not detected by x-rays, there is also no way to observe and recognize this error which is potentially harmful to the patient. Good catheter placement is also a problem in epidural and intrathecal infusions as well as in intravenous application where the needle is placed outside the vein (infiltration). In general, intravenous applications have a large fluid evacuation capability, resulting in a small increase of pressure with higher flow. In contrast thereto, in other types of application (subQ, epidural, intrathecal) the pressure of flow is built up pressure in a transient flow step up like a bolus, and reduced slower in a flow step down.
  • U.S. Pat. No. 8,551,038 discloses an infusion system in which the treatment results and side-effects of infusion are monitored remotely through a server as pumps are online exchanging data through or after therapy.
  • U.S. Pat. No. 5,609,576, U.S. Pat. No. 5,803,917, U.S. Pat. No. 5,087,245, U.S. Pat. No. 5,609,576, U.S. Pat. No. 7,022,116, U.S. Pat. No. 2,755,680, U.S. Pat. No. 4,898,576, U.S. Pat. No. 5,087,245 and U.S. Pat. No. 6,158,965 deal with the filtering or calculating of pressure downstream data in one or more flow levels due to a calculation of the line's flow resistance.
  • It is an object of the present invention to take into account pressure transience for medically useful conclusions and the provision of alarms.
  • In order to achieve the aforementioned and further objects, according to the present invention, there is provided a method for processing infusion data and an infusion pump system.
  • Further preferred embodiments and modifications of the present invention are defined in the dependent claims.
  • According to the present invention, processed are infusion pressure statistics considering both a steady state and a transient state, below occlusion level, for new medical practice and decisions per therapy. Pressure measurements in clinical trials on several infusion sites (not only intravenous) show that pressure/time graphs define an exponential type like a built-up infusion set occlusion pressure. So, according to the present invention, the pressure is monitored only at steady state and the decay from a given pressure with the pump stopped. This gives another great advantage that an infusion pump is not an ideal current source, as assumed in prior art models, so that the transient measuring when the pump is stopped for few seconds, gives accurate results. The present invention makes use of downstream pressure monitoring not only for short-term deductions concerning leaks but recording an event/pressure profile useful for extraction of useful medical decisions, like ones needed for regional analgesia nerve blocks, but also for long-term conclusions like obstruction of the central venous catheter, venous-SVC stenosis, and catheter blockage in the Parkinson's disease intestinal catheter.
  • The intention of the present invention is to provide an infusion pump system with downstream pressure recording means, to be used within both a short term (one infusion) and a long term over several infusions, for detection of defined problems, as for example infusion catheter blockage, SVC stenosis in chronic patients and regional analgesia nerve blockage complications, and for short term detection of medically useful information, like perineural infusion or generally pain treatment, over one single infusion lasting a few days.
  • Prediction of blockage before the venous catheter actually blocks has significant advantages for the patient, since even at an advanced stage of blockage, if even a small quantity of liquid is able to pass through the catheter, it can be cleaned, thus preventing a surgical intervention for replacement.
  • According to the present invention the type of fluid used in each infusion is recorded, a sampling time interval per therapy having single or multiple infusions duration is defined, and then an average downstream pressure during this interval including maximum pressure and maximum pressure difference is obtained. A pressure reading is always recorded at infusion rate transients even within an interval. Then, both rate and interval pressure statistics are recorded. Further, provided are means to display statistics graphs for one or more infusions, maybe over a day or many months, and for an algorithmic processing of said pressure/rate profiles for extracting medically useful information.
  • Said time interval is limited by data recording capacity of the system, it can be 10 seconds to one hour. A knowledge data base is maintained for each therapy, with fluid/rate/pressure/transient pressure normal data being stored and processed wherein abnormal data can issue a warning.
  • According to the present invention, used is a pressure threshold below occlusion, defined per therapy and per site type (subcutaneous, intravenous etc.) and possibly user. When said threshold is reached, special resistance of flow and time constants are measured and added to pressure statistics stored in the data base of the pump or the server (distributed pump system). When pressure statistic limits as defined by user are exceeded, an alarm or warning according to the therapy and risks identified is issued. According to the present invention, the knowledge is built over a long term, through experience by considering false alarms vs. correct alarms. The risk of percentage of false alarms is taken by user, who defines the amount of false alarms he can accept, just to prevent a higher risk of real alarms that need possibly surgical intervention. So warning and/or alarm limits or warning communication (to whom/when) are also defined by a user group or the user and the therapy. For example, in a clinical study on parenteral nutrition pressure monitoring over hundreds of patients and almost a year of monitoring, only 2 patients showed pressure peaks being higher than 0.5 bar wherein one of them needed a medical intervention (venoplasty) and in the other case there was a false alarm. However, the risk of false alarms defining 0.5 bar as pressure limit for a catheter vein problem warning is definitively small (1 false over hundreds no-alarm). For building up a system knowledge, doctors report false and real alarms to the system stored in the data base per therapy and also user group. So, when a user or doctor selects some alarm and/or warning parameters for a therapy and patient type (fat/slim, race etc.), the system will warn him about the percentage of error these parameters can expect.
  • Preferably, this is possible by a telemedicine system described in U.S. Pat. No. 8,551,038 in combination with the present invention, wherein a parametric definition of alarm and/or warning, communication type and urgency (text on mobile, email, alarm on pump), pressure level statistics, resistance of flow, transient time constant and sampling time are defined per therapy, gained experience and user risk acceptance so they are not fixed as in the prior art. Provided are means to users to define the parameters and possibly some already known propositions gained from ongoing clinical trials in parenteral nutrition and peripheral nerve blockage. This information may help clinicians modify early the infusion parameters of regional analgesia that depend a lot from how much distant is the catheter from the nerve.
  • After all, an aspect of the present invention is the recording of pressure data below occlusion level and creating a graph of said data for deduction of medically useful information. A further aspect of the present invention is the definition of a time interval per therapy for pressure data recording which time interval reduces the data to be sent.
  • A further aspect of the present invention is the measurement of the pressure data not only from one pump as in the prior art, but for many pumps and in many times so as to build up a group knowledge like an ongoing clinical trial.
  • Preferably, downstream pressure statistics data are grouped in accordance with a) therapy, b) drug, c) way of introduction (intravenous, epidural, perineural, subcutaneous etc.), d) type of delivery (needle, central venous catheter, small perineural catheter, angled needle etc.), e) reported problem type, f) alarm and/or warning level, and g) user type so as to show results according to choices from some or all the aforementioned groups a to g. So, it can be asked e.g. for all reported catheter “type z”, “obstructions” and “statistics” during the “last month of use for each catheter”, so that a query is transferred to the database. Problems are preferably reported to the system by caregivers with reference to category (obstruction of catheter, obstruction of a vein, semi-obstruction etc) and part used (e.g. catheter brand or a model) so as to build up a knowledge on which group of data a problem arises. A risk factor of statistical data and/or reported problems is evaluated by the user or by an automatic computerized process (e.g. comprising neural networks or other artificial intelligence or data filtering and/or algorithmic processing). Preferably, alarm and warning limits are chosen per user after his risk analysis or acceptance, and then applied to the system, i.e. in particular an alarm appropriate for the user so that he/she does not need to be bothered by many or too many of the “medical type” alarms, and/or a warning for infiltration on P-average <x, and τ<y or intraneural alarm if Pmax >x and τ>y or the need of the catheter to be cleaned if A >x and τ>y etc., wherein this process is not static as in the prior art, but changing as knowledge is building up.
  • According to a further aspect of the present invention, there is provided a distributed infusion pump system comprising
      • means for measuring and calculating downstream pressure statistics per infusion and per rate,
      • a database to store said statistics linked per infusion attributes (date, patient type, name, delivery route, catheter type, needle type, drug, therapy),
      • means to report and link specific infusion's attributes into said database a health thread or event (catheter block, infiltration, intraneural placement),
      • means to query all database comprising thousands of patients and infusions over long time period according to attributes and events and statistics, so as to decide on infusion pump limits for warning/alarm per heath thread or event type, and
      • means to transfer these alarm/warning limits to the pump system as alarm/warning per type.
  • In the following, preferred embodiments of the present invention will be described with reference to the accompanying drawings, wherein
  • FIG. 1 is a graph showing a typical long term pressure recording in parenteral nutrition for various fluids,
  • FIG. 2 is a graph showing a transition from a first flow and pressure to a second flow and pressure,
  • FIG. 3 shows a typical infusion drug delivery chain,
  • FIG. 4 is a graph showing a loading dose and intraneural pressure long drop, and
  • FIG. 5 is a graph showing a standard subcutaneous loading dose pressure transient.
  • FIG. 3 schematically shows a typical drug delivery chain comprising an infusion set 1, a connector 2, a catheter 3 and a tissue or vein 4 wherein the connector 2 couples the infusion set 1 with the catheter 3 which is introduced into the tissue or vein 4.
  • In parenteral nutrition, there are different types of infusion, i.e. for main nutrition and for hydration or combination of both (dilutions). For nutrition the average flow speed for adults is 120 ml/hr, and for hydration it is the maximum pump flow, e.g. 400 ml/hr. Typical parenteral nutrition pressure graphs are shown in FIG. 1. For a long term recording, the pump initially records statistical information about downstream pressure of the infusion such as average pressure, maximum pressure and maximum pressure difference, together with how many peaks happened, and duration per peak, for the entire infusion. When connected to a so-called distributed system as described in U.S. Pat. No. 8,551,038, pressure interval (one hour), statistics and flow profile data are uploaded to a telemedicine server. Pressure statistics include a calculated flow resistance A and a transient time constant τ. Average can be a real average or the result of digital filtering on the pressure data. Pump system (pump screen or web server) can display graphs of statistical curves, or warn the user if abnormal peaks or trends are found.
  • The system makes time-stamped recordings of the pressure statistics and/or rates, so that a physician or an automated decision-making system evaluates the increase of pressure below occlusion and consequently informs the patient, who can also monitor the pressure statistic curves on the pump. Thanks to local and remote long term recording and the display of pressure statistics, surgical intervention can be avoided. A clinical trial in a hospital has shown that the recording of the statistics on output pressure for each infusion rate in each patient demonstrates the catheter's tendency to block (several months recording).
  • In intravenous infusions such as a parenteral nutrition, pressure is usually between 0.1 and 0.5 bar. Pressure difference peaks of more than 0.5 bar and, hence, below occlusion level have showed Superior Vena Cava stenosis needing venoplasty.
  • Resistance of flow in an open end tube is A=P/F where P is a steady state pressure for a flow (infusion rate) F, wherein a general tendency for block, i.e. an increase of resistance of flow such as an increase of pressure at a constant flow, can be observed. In the parenteral nutrition example above, said pressure statistics comprise such resistance of flow. In the prior art, resistance of flow at steady state of intravenous infusions is calculated by the formula
  • A = P 2 - P 1 F 2 - F 1 .
  • FIG. 2 shows a transition from flow F1 and pressure P1 to flow F2 and pressure P2.
  • In another embodiment of the present invention, pressures and corresponding flows recorded in nutrition and hydration (or under different speeds for the same liquid) are used to calculate the resistance of flow giving indications on the catheter condition. So, the resistance of flow A is calculated from different pressure and flow which occur with the different infusions and/or even on different days, and this is new in the art. With respect thereto, it is referred to FIG. 1 which as an example shows graphs representing three different flows F1, F2 and F3 under different pressure P1, P2 and P3, respectively. Due to the differing viscosity of different fluids, the flow resistance calculated is not the real figure, but its trend over time reveals whether or not there is a verge of blockage and the catheter needs cleaning. To compensate this, normalized formula for resistance of flow is calculated as
  • A = ( P 2 - P 1 ) * Vw ( ( F 2 - F 1 ) * Vs
  • where viscosity of water Vw and viscosity of drug Vs have been added which for drugs with high viscosity as immunoglobulin is important.
  • In another embodiment of the present invention, the pump can run a slow flow plus a fast flow and calculate the flow resistance, at the beginning or the end of the infusion wherein the end seems best because sugar intake has been completed and the adult patient is not at risk, i.e. flow resistance calculated within one single infusion.
  • The local display at the pump or the remote, mobile or internet application, displays the pressure statistics and corresponding flow and also potentially the flow resistance in a diagram chronologically where the trend appears. The derivative of the pressure curve over time, i.e. the pressure's tendency to increase over time (days, weeks, months or years), is also displayed, for easy computation by an automated system, the patient or the physician, so as to create a figure or drawing of conclusions regarding the potential blockage of the catheter in the near future. The derivative during and after a bolus (high rate specific volume infusion) gives useful information especially at subcutaneous infusions, where cavities (very slow change) or dead space and/or high change (inside a nerve) can be detected.
  • The system according to the present invention can also be used in cases other than central venous catheters, e.g. for Duodopa infusions in patients with Parkinson's disease, to prevent the blockage of duodenal stomach or peritoneal catheters, in infusions for peripheral analgesia where the involuntary relocation of the catheter near the nerve shows a sudden change in the output pressure, translated into alterations in the analgesia, so that changes to the anaesthetic dosage are required.
  • The resistance of flow is independent of flow. Bolus time may not be generally enough to reach a pressure steady state for the flow rate, so that a measurement of transient fall times is taken for calculating a time constant τ.
  • The flow resistance is not only measured in subcutaneous, epidural and intrathecal infusions, as pressure is built up relatively fast after a flow step, whereas a decay is relatively slow. So, according to the present invention, a transient response to flow and/or pressure only in the pressure decay after a high rate down to zero rate is measured.
  • Some measured curves in the data have an almost linear slope and some are exponential as shown as an example in FIGS. 4 and 5. So, the time constant in the decay from step to zero rate is measured wherein the found curve is always of the same type. This eliminates another type of error, i.e. the assumption of an ideal flow source in the prior art model, as the flow rate is not ideal, resulting in the introduction of errors. Zero rate is selected so that no forced flow intervenes in the flow decay, also because the steady state pressure of the asymptote Pz is known. This can be the medium pressure measured when after purge the pump is connected to the patient, just before the infusion starts, or measured close to a low infusion rate before a high flow step (bolus/loading dose). So, the transient time constant and resistance of flow are calculated easily and relatively fast.
  • This measurement is also used in intravenous infusions, stopping for some seconds a relatively high rate (above 100 ml/hr) usual as in intravenous infusions.
  • In subcutaneous infusions, such as regional analgesia, with a catheter placed in surgery, the recording time interval can be 30 seconds, and the transient pressure after a maximum rate bolus is recorded followed by recording the decay of pressure at a generally low following basal rate, to show if the catheter is placed into a nerve which is potentially harmful to the patient. The pressure rise and fall times are different depending on the placement of a peripheral nerve blocking catheter in surgery. This can give information regarding a reposition of the catheter and the avoidance of complications or a prediction for a based infusion and bolus needed, when the patient goes home. FIG. 5 shows a normal transient response during and after a loading dose and bolus; and FIG. 4 shows an intraneural transient response i.e. with limited space and elasticity so that the pressure rises abruptly and decays slowly.
  • The decay initial linear portion of the exponential gives points (P,t) defining through linear regression (least squares) a slope angle α (FIG. 5) which in theory (initial slope method) intersects the steady state pressure Pz at time point τ. From that triangle τ calculated by the formula τ=(P−Pz)*sin(α) where P is the starting pressure before decay, when zero infusion rate starts, and Pz is the zero rate pressure known as above. This measurement can last a few seconds. Alternatively for fast decaying curves, point (τ, 37% (P−Px)) defines τ with the pressure Pt=37% of (P−Pz) when the time point t=τ is constant.
  • As described above, according to the present invention, means are provided for recording a downstream pressure statistics of an infusion at specific time intervals, with mean, maximum and minimum (or maximum difference) pressure within the interval, wherein the intervals depend on the therapy type, and a calculation of statistical methods so to extract useful medical information, such as resistance of flow A=P/F at steady state, and formula A when pressure and flow differences and a transient time constant τ have been obtained, and where said recording can be provided for more than one infusions on the same patient and same catheter, means for displaying such raw and calculated statistics (in contrast to also uploaded and recorded feedback from reported problems) so that medically useful information can easily be deducted from an automated system or the doctor wherein this information gives parameters for the user to define limits per therapy, and wherein a knowledge base is structured by user feedbacks on limits used and false or correct alarms given by the system so that continuous improvement of results can be achieved through telemedicine.

Claims (24)

1. A method for processing infusion data, comprising:
measuring a downstream pressure and providing downstream pressure measurement results per infusion and per rate;
providing downstream pressure statistics on the basis of the downstream pressure measurement results per infusion and per rate;
storing in a database the downstream pressure statistics and linking the stored downstream pressure statistics with infusion attributes in particular including date, patient type, name, delivery route, catheter type, needle type, drug and therapy, and linking the infusion attributes with a health thread or event in particular caused by a catheter block, infiltration and intraneural placement, so that the database includes a plurality of patient and infusion data over a long time period according to the attributes and events and statistics;
querying the database so as to decide on the provision of infusion pump limits for warning and/or alarm per health thread or event type; and
transferring these alarm and/or warning limits to a pump system as an alarm and/or warning per health thread or event type.
2. The method according to claim 1, wherein the downstream pressure statistics comprise a resistance of flow A and a time constant τ.
3. The method according to claim 2, wherein the time constant τ is determined after the resistance of flow A reaches a predetermined limit, or the pressure reaches a predetermined downstream occlusion level, where the infusion stops (rate=0) for the measurement and continues or waits for alarm release.
4. The method according to claim 2, wherein the time constant τ is determined after a bolus end, and the infusion is stopped until the time constant τ is determined.
5. The method according to claim 2, wherein the resistance of flow A is determined from different infusions with different rates and drugs on the same patient, preferably with different attributes.
6. The method according to claim 1, wherein a zero rate downstream pressure is measured just before starting an infusion.
7. The method according to claim 1, wherein the attributes are grouped in a query to smaller groups e.g. as “catheter” instead of catheter brand or part number.
8. The method according to claim 1, wherein alarms and warnings are distributed to users via communication means, including at least one of by showing a message on a web page when consulting, by mobile phone text messages, email and/or alarm on a pump.
9. The method according to claim 1, wherein downstream pressure statistics comprising maximum pressure, average pressure and maximum pressure difference are reported with measuring intervals which can be different per therapy and/or in accordance with the current therapy situation.
10. An infusion pump system for infusion of fluids into a human or an animal body, comprising:
a measurement unit which is configured to measure downstream pressure;
a recording unit which is configured to record downstream pressure measurement results; and
a display which is adapted to display downstream pressure measurement results, wherein the measurement and recording units are configured to measure and record the downstream pressure continuously or in intervals for a period of at least one week.
11. The infusion pump system according to claim 10, further comprising stopping means which is configured to stop the infusion activity while downstream pressure measurement is performed.
12. The infusion pump system according to claim 10, wherein the recording unit is provided for recording the measurement results for a period ≧1 month, preferably ≧1 year.
13. The infusion pump system according to claim 10, wherein the recording unit is further configured to record the infusion speed.
14. The infusion pump system according to claim 10, further comprising a comparing unit which is configured to compare the pressure measurement results with a threshold value T which is provided for indicating a risk of blockage of the infusion and is lower than a threshold value indicating actual blockage.
15. The infusion pump system according to claim 14, wherein the threshold value T is dependent upon the kind of the infusion fluid, the way of introduction of the infusion fluid and/or type of delivery means.
16. The infusion pump system according to claim 10, further comprising a remote recording unit and a transmitting unit which is configured to submit downstream pressure measurement results to the remote recording unit.
17. The infusion pump system according to claim 16, wherein the remote recording unit is configured to receive data from more than one infusion pump.
18. The infusion pump system according to claim 14, further comprising a remote recording unit and a transmitting unit which is configured to submit downstream pressure measurement results to the remote recording unit and the remote recording unit is configured to receive data from more than one infusion pump, wherein the comparing unit is configured to have access to the data recorded on the remote recording unit, wherein the data from each pump are grouped in dependence of the kind of the infusion fluid, the way of introduction of the infusion fluid and/or type of delivery means and the threshold value T is provided for each independent group to be compared with the data from this group.
19. The infusion pump system according to claim 16, further comprising a receiving unit which is configured to receive feedback information from caregivers about the reason for blockage and/or risk of blockage indicated by the system.
20. The infusion pump system according to claim 14, further comprising a calculation unit which is configured to recalculate the threshold value T dependent upon statistical data of the downstream pressure measurement results and/or feedback information.
21. The infusion pump system according to claim 20, wherein the calculation unit comprises artificial intelligence, especially neuronal networks.
22. The infusion pump system according to claim 14, further comprising an alarm unit which is configured to give an alarm if a pressure value ≧threshold value T is measured.
23. The infusion pump system according to claim 14, further comprising a threshold amending unit which is configured to amend the threshold value T by the patient.
24. The infusion pump system according to claim 10, wherein pressure results include minimum, maximum, average and/or max difference of pressure during sampling period.
US14/182,111 2013-02-15 2014-02-17 Method for Processing Infusion Data and an Infusion Pump System Abandoned US20140236119A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US14/791,989 US11164667B2 (en) 2013-02-15 2015-07-06 Method for processing infusion data and an infusion pump system
US17/487,135 US20220008654A1 (en) 2013-02-15 2021-09-28 Method for processing infusion data and an infusion pump system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20130100089 2013-02-15
GR20130100089 2013-02-15

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/791,989 Division US11164667B2 (en) 2013-02-15 2015-07-06 Method for processing infusion data and an infusion pump system

Publications (1)

Publication Number Publication Date
US20140236119A1 true US20140236119A1 (en) 2014-08-21

Family

ID=50151124

Family Applications (3)

Application Number Title Priority Date Filing Date
US14/182,111 Abandoned US20140236119A1 (en) 2013-02-15 2014-02-17 Method for Processing Infusion Data and an Infusion Pump System
US14/791,989 Active US11164667B2 (en) 2013-02-15 2015-07-06 Method for processing infusion data and an infusion pump system
US17/487,135 Pending US20220008654A1 (en) 2013-02-15 2021-09-28 Method for processing infusion data and an infusion pump system

Family Applications After (2)

Application Number Title Priority Date Filing Date
US14/791,989 Active US11164667B2 (en) 2013-02-15 2015-07-06 Method for processing infusion data and an infusion pump system
US17/487,135 Pending US20220008654A1 (en) 2013-02-15 2021-09-28 Method for processing infusion data and an infusion pump system

Country Status (2)

Country Link
US (3) US20140236119A1 (en)
EP (2) EP2767919B1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150374902A1 (en) * 2012-12-31 2015-12-31 Gambro Lundia Ab Occlusion detection in delivery of fluids
CN110087712A (en) * 2016-10-07 2019-08-02 康尔福盛303公司 System and method for controlling infusion pump
US10589016B2 (en) 2015-04-15 2020-03-17 Gambro Lundia Ab Treatment system with infusion apparatus pressure priming
US11429725B1 (en) * 2018-04-26 2022-08-30 Citicorp Credit Services, Inc. (Usa) Automated security risk assessment systems and methods
DE102022118179A1 (en) 2022-07-20 2024-01-25 B. Braun Melsungen Aktiengesellschaft Bolus reduction method, prognostic method, safety device and medical pump

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881783B2 (en) * 2015-11-20 2021-01-05 Fenwal, Inc. Processing infusion pump data for presentation on operator interface
CN110841142B (en) * 2019-10-22 2022-03-08 江苏爱朋医疗科技股份有限公司 Method and system for predicting blockage of infusion pipeline
CN110841143B (en) * 2019-10-22 2022-03-08 江苏爱朋医疗科技股份有限公司 Method and system for predicting state of infusion pipeline

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690673A (en) * 1985-11-26 1987-09-01 Imed Corporation Dual mode I.V. infusion device with distal sensor
US4836752A (en) * 1987-11-02 1989-06-06 Fisher Scientific Company Partial restriction detector
US5096385A (en) * 1989-11-08 1992-03-17 Ivac Corporation Method and system for upstream occlusion detection
US5116203A (en) * 1990-03-15 1992-05-26 Abbott Laboratories Detecting occlusion of proximal or distal lines of an IV pump
US5304127A (en) * 1992-04-03 1994-04-19 Sharp Kabushiki Kaisha Infusion apparatus able to recognize an appropriate time for servicing
US5356378A (en) * 1992-01-22 1994-10-18 Ivac Corporation Fluid line condition detection
US5445622A (en) * 1994-12-20 1995-08-29 Brown; Eric W. Flow switch device for medical applications
US5814015A (en) * 1995-02-24 1998-09-29 Harvard Clinical Technology, Inc. Infusion pump for at least one syringe
US5827223A (en) * 1995-08-31 1998-10-27 Alaris Medical Systems, Inc. Upstream occulsion detection system
US5935099A (en) * 1992-09-09 1999-08-10 Sims Deltec, Inc. Drug pump systems and methods
US6422057B1 (en) * 1998-09-29 2002-07-23 Deltec, Inc. Drug pump testing system and methods
US8065161B2 (en) * 2003-11-13 2011-11-22 Hospira, Inc. System for maintaining drug information and communicating with medication delivery devices
US20110295191A1 (en) * 2010-05-25 2011-12-01 Alcon Research, Ltd. Infusion Pressure Monitoring System

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2755680A (en) 1954-07-15 1956-07-24 Landis & Gyr Ag Instrument servomotor for torque amplification in measuring apparatus and the like
US4534756A (en) * 1983-04-11 1985-08-13 Ivac Corporation Fault detection apparatus and method for parenteral infusion system
US4530696A (en) * 1983-06-13 1985-07-23 Institute Of Critical Care Medicine Monitor for intravenous injection system for detecting occlusion and/or infiltration
US4898576A (en) 1986-06-06 1990-02-06 Philip James H Intravenous fluid flow monitor
US4863425A (en) * 1987-12-04 1989-09-05 Pacesetter Infusion, Ltd. Patient-side occlusion detection system for a medication infusion system
US5087245A (en) 1989-03-13 1992-02-11 Ivac Corporation System and method for detecting abnormalities in intravascular infusion
US5695473A (en) 1994-07-27 1997-12-09 Sims Deltec, Inc. Occlusion detection system for an infusion pump
US5803917A (en) 1994-09-13 1998-09-08 Alaris Medical Systems, Inc. Fluid flow resistance monitoring system
US5609576A (en) 1994-09-13 1997-03-11 Ivac Medical Systems, Inc. Fluid flow impedance monitoring system
US6158965A (en) 1996-07-30 2000-12-12 Alaris Medical Systems, Inc. Fluid flow resistance monitoring system
US6551243B2 (en) * 2001-01-24 2003-04-22 Siemens Medical Solutions Health Services Corporation System and user interface for use in providing medical information and health care delivery support
US20050055242A1 (en) * 2002-04-30 2005-03-10 Bryan Bello System and method for medical data tracking, analysis and reporting for healthcare system
US20050038680A1 (en) 2002-12-19 2005-02-17 Mcmahon Kevin Lee System and method for glucose monitoring
US7022116B2 (en) 2003-10-23 2006-04-04 Medtronic, Inc. Method for monitoring bolus delivery
US8182461B2 (en) * 2003-11-04 2012-05-22 Smiths Medical Asd, Inc. Syringe pump rapid occlusion detection system
US20090093774A1 (en) * 2007-10-04 2009-04-09 Baxter International Inc. Ambulatory pump with intelligent flow control
WO2009124134A2 (en) * 2008-04-01 2009-10-08 Smiths Medical Md, Inc. Software features for medical infusion pump
WO2010102069A2 (en) * 2009-03-04 2010-09-10 Masimo Corporation Medical monitoring system
RU2553935C2 (en) 2009-05-05 2015-06-20 Кэафьюжн 303, Инк. Model-based infusion site control unit
EP2519280B1 (en) * 2009-12-28 2015-01-28 Gambro Lundia AB Method and device for detecting a configuration of withdrawal and return devices
US8551038B2 (en) 2010-07-19 2013-10-08 Micrel Medical Devices S.A. Pump infusion system
EP2605813B1 (en) * 2010-08-17 2018-08-01 University of Florida Research Foundation, Inc. Intelligent drug delivery system to optimizing medical treatment or therapy.
US8690855B2 (en) * 2010-12-22 2014-04-08 Medtronic Minimed, Inc. Fluid reservoir seating procedure for a fluid infusion device
EP2948204B1 (en) * 2013-01-28 2021-08-25 Smiths Medical ASD, Inc. Medication safety devices and methods

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690673A (en) * 1985-11-26 1987-09-01 Imed Corporation Dual mode I.V. infusion device with distal sensor
US4836752A (en) * 1987-11-02 1989-06-06 Fisher Scientific Company Partial restriction detector
US5096385A (en) * 1989-11-08 1992-03-17 Ivac Corporation Method and system for upstream occlusion detection
US5116203A (en) * 1990-03-15 1992-05-26 Abbott Laboratories Detecting occlusion of proximal or distal lines of an IV pump
US5356378A (en) * 1992-01-22 1994-10-18 Ivac Corporation Fluid line condition detection
US5304127A (en) * 1992-04-03 1994-04-19 Sharp Kabushiki Kaisha Infusion apparatus able to recognize an appropriate time for servicing
US5935099A (en) * 1992-09-09 1999-08-10 Sims Deltec, Inc. Drug pump systems and methods
US5445622A (en) * 1994-12-20 1995-08-29 Brown; Eric W. Flow switch device for medical applications
US5814015A (en) * 1995-02-24 1998-09-29 Harvard Clinical Technology, Inc. Infusion pump for at least one syringe
US5827223A (en) * 1995-08-31 1998-10-27 Alaris Medical Systems, Inc. Upstream occulsion detection system
US6422057B1 (en) * 1998-09-29 2002-07-23 Deltec, Inc. Drug pump testing system and methods
US8065161B2 (en) * 2003-11-13 2011-11-22 Hospira, Inc. System for maintaining drug information and communicating with medication delivery devices
US20110295191A1 (en) * 2010-05-25 2011-12-01 Alcon Research, Ltd. Infusion Pressure Monitoring System

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150374902A1 (en) * 2012-12-31 2015-12-31 Gambro Lundia Ab Occlusion detection in delivery of fluids
US9833561B2 (en) * 2012-12-31 2017-12-05 Gambro Lundia Ab Occlusion detection in delivery of fluids
US10589016B2 (en) 2015-04-15 2020-03-17 Gambro Lundia Ab Treatment system with infusion apparatus pressure priming
CN110087712A (en) * 2016-10-07 2019-08-02 康尔福盛303公司 System and method for controlling infusion pump
US11517671B2 (en) 2016-10-07 2022-12-06 Carefusion 303, Inc. Systems and methods for controlling an infusion pump
US11429725B1 (en) * 2018-04-26 2022-08-30 Citicorp Credit Services, Inc. (Usa) Automated security risk assessment systems and methods
DE102022118179A1 (en) 2022-07-20 2024-01-25 B. Braun Melsungen Aktiengesellschaft Bolus reduction method, prognostic method, safety device and medical pump

Also Published As

Publication number Publication date
EP2767919A1 (en) 2014-08-20
US11164667B2 (en) 2021-11-02
EP3449961A1 (en) 2019-03-06
US20220008654A1 (en) 2022-01-13
US20150306310A1 (en) 2015-10-29
EP2767919B1 (en) 2019-01-30
EP3449961B1 (en) 2021-03-31

Similar Documents

Publication Publication Date Title
US20220008654A1 (en) Method for processing infusion data and an infusion pump system
US10188792B2 (en) Automated pressure limit setting method and apparatus
US20160310668A1 (en) System for managing glucose levels in patients with diabetes or hyperglycemia
CN103432651B (en) A kind of intelligent anesthesia control system of closed loop
JP6457508B2 (en) Infusion planning system
EP2257217A1 (en) Hemodynamic monitors and alarms
US20230137546A1 (en) Alarm system for intravenous pump or catheter based upon fuzzy logic
Vitoux et al. Frequency and duration of infusion pump alarms: establishing national benchmarks
US20210090707A1 (en) Processing infusion pump data for presentation on operator interface
EP4002379A1 (en) System comprising a device, method and computer program for controlling the administration of medication to a patient
JP6530013B2 (en) Blood purification system
US20200038587A1 (en) Systems and methods for monitoring and controlling a state of a subject during volume resuscitation
US20240062866A1 (en) Alert management in fluid delivery system
EP4306049A1 (en) Automatic drug infusion monitoring device with timed samples
JP7356227B2 (en) Medical information processing equipment and medical information system

Legal Events

Date Code Title Description
AS Assignment

Owner name: MICREL MEDICAL DEVICES S.A., GREECE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TSOUKALIS, ACHILLEAS;REEL/FRAME:032473/0108

Effective date: 20140305

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION